SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Pedersen Andreas) "

Search: WFRF:(Pedersen Andreas)

  • Result 1-10 of 158
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Beal, Jacob, et al. (author)
  • Robust estimation of bacterial cell count from optical density
  • 2020
  • In: Communications Biology. - : Springer Science and Business Media LLC. - 2399-3642. ; 3:1
  • Journal article (peer-reviewed)abstract
    • Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data.
  •  
2.
  • Hollestelle, Antoinette, et al. (author)
  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
  • 2016
  • In: Gynecologic Oncology. - : Elsevier BV. - 0090-8258 .- 1095-6859. ; 141:2, s. 386-401
  • Journal article (peer-reviewed)abstract
    • Objective Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3′ UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particular subgroups, were relatively small. Therefore, we comprehensively evaluated ovarian and breast cancer risks as well as clinical outcome associated with rs61764370. Methods Centralized genotyping and analysis were performed for 140,012 women enrolled in the Ovarian Cancer Association Consortium (15,357 ovarian cancer patients; 30,816 controls), the Breast Cancer Association Consortium (33,530 breast cancer patients; 37,640 controls), and the Consortium of Modifiers of BRCA1 and BRCA2 (14,765 BRCA1 and 7904 BRCA2 mutation carriers). Results We found no association with risk of ovarian cancer (OR = 0.99, 95% CI 0.94-1.04, p = 0.74) or breast cancer (OR = 0.98, 95% CI 0.94-1.01, p = 0.19) and results were consistent among mutation carriers (BRCA1, ovarian cancer HR = 1.09, 95% CI 0.97-1.23, p = 0.14, breast cancer HR = 1.04, 95% CI 0.97-1.12, p = 0.27; BRCA2, ovarian cancer HR = 0.89, 95% CI 0.71-1.13, p = 0.34, breast cancer HR = 1.06, 95% CI 0.94-1.19, p = 0.35). Null results were also obtained for associations with overall survival following ovarian cancer (HR = 0.94, 95% CI 0.83-1.07, p = 0.38), breast cancer (HR = 0.96, 95% CI 0.87-1.06, p = 0.38), and all other previously-reported associations. Conclusions rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers. Therefore, genotyping this variant has no clinical utility related to the prediction or management of these cancers.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 158
Type of publication
journal article (148)
doctoral thesis (3)
licentiate thesis (2)
reports (1)
other publication (1)
conference paper (1)
show more...
research review (1)
book chapter (1)
show less...
Type of content
peer-reviewed (144)
other academic/artistic (13)
pop. science, debate, etc. (1)
Author/Editor
Chen, L (32)
Aad, G (32)
Abbott, B. (32)
Abdinov, O (32)
Zwalinski, L. (32)
Gregersen, K. (32)
show more...
Kalderon, C.W. (32)
Poettgen, R. (32)
Aben, R. (32)
Abreu, H. (32)
Abreu, R. (32)
Adye, T. (32)
Agatonovic-Jovin, T. (32)
Ahmadov, F. (32)
Aielli, G. (32)
Alberghi, G. L. (32)
Albert, J. (32)
Albrand, S. (32)
Aleksa, M. (32)
Aleksandrov, I. N. (32)
Alexander, G. (32)
Alexopoulos, T. (32)
Alhroob, M. (32)
Alimonti, G. (32)
Alio, L. (32)
Aloisio, A. (32)
Alonso, A. (32)
Alonso, F. (32)
Alpigiani, C. (32)
Altheimer, A. (32)
Alviggi, M. G. (32)
Amako, K. (32)
Amelung, C. (32)
Amidei, D. (32)
Amorim, A. (32)
Amoroso, S. (32)
Amram, N. (32)
Amundsen, G. (32)
Anastopoulos, C. (32)
Ancu, L. S. (32)
Andari, N. (32)
Andeen, T. (32)
Anders, G. (32)
Anderson, K. J. (32)
Andreazza, A. (32)
Andrei, V. (32)
Angelidakis, S. (32)
Anger, P. (32)
Angerami, A. (32)
Anghinolfi, F. (32)
show less...
University
Lund University (84)
Uppsala University (65)
Karolinska Institutet (45)
Stockholm University (43)
Royal Institute of Technology (36)
Umeå University (18)
show more...
Linköping University (15)
University of Gothenburg (13)
Chalmers University of Technology (11)
Örebro University (6)
Jönköping University (5)
University of Skövde (4)
Mid Sweden University (3)
Stockholm School of Economics (2)
Swedish Museum of Natural History (2)
Swedish University of Agricultural Sciences (2)
Halmstad University (1)
University West (1)
Malmö University (1)
Högskolan Dalarna (1)
show less...
Language
English (157)
Danish (1)
Research subject (UKÄ/SCB)
Natural sciences (80)
Medical and Health Sciences (67)
Engineering and Technology (9)
Social Sciences (5)
Humanities (5)
Agricultural Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view